Cargando…
SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer
Dysregulation of transcription factors (TFs) is associated with tumor progression, but little is known about TF expression patterns in the context of gastric cancer (GC) metastasis. Using array-based profile analysis, we found that 22 TFs showed differential activities between GC cell lines with low...
Autores principales: | Zhao, X, He, L, Li, T, Lu, Y, Miao, Y, Liang, S, Guo, H, Bai, M, Xie, H, Luo, G, Zhou, L, Shen, G, Guo, C, Bai, F, Sun, S, Wu, K, Nie, Y, Fan, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227147/ https://www.ncbi.nlm.nih.gov/pubmed/25080937 http://dx.doi.org/10.1038/cdd.2014.109 |
Ejemplares similares
-
Long noncoding RNA XIST expedites metastasis and modulates epithelial–mesenchymal transition in colorectal cancer
por: Chen, Dong-liang, et al.
Publicado: (2017) -
DACH1 inhibits SNAI1-mediated epithelial–mesenchymal transition and represses breast carcinoma metastasis
por: Zhao, F, et al.
Publicado: (2015) -
Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial–mesenchymal transition in human hepatocellular carcinoma
por: Jia, R-J, et al.
Publicado: (2014) -
Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling
por: Shi, Z-M, et al.
Publicado: (2017) -
MiR-199 Reverses the Resistance to Gemcitabine in
Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal
Transition
por: Wei, Weitian, et al.
Publicado: (2021)